Julien de Salaberry

CEO and a co-founder of Galen Growth, Julien also leads Galen Growth’s Pharmaceutical and other healthcare client engagements, leveraging over 25 years of experience in healthcare with leading brands including Eli Lilly, Boston Scientific, Baxter, GSK, Merck & Co.

Julien has a deep understanding of organic and inorganic growth in healthcare in both mature and developing markets, addressing awareness, access and affordability challenges.

Julien co-authored iDirupted in 2014 and Living in the Age of the Jerk in 2020.   Both books are a focus on technology innovation and its impact on humans, our ecosystem and the economy. 

As well as his leadership of Galen Growth, Julien is an experienced SME Non-Executive Director, and regular speaker and writer on the value of digital health innovation.

Prior to his career in healthcare, Julien served in the British Armed Forces. Decorated with the Gulf GSM Kuwait Clasp Medal (1991) and Bosnia NATO Medal (1993).

Helene Champoux

Helene is the COO of Galen Growth and is a founding team member. She has built the commercial operations of the company and has been a key player in developing Galen Growth as the go-to-reference for Global HealthTech data, trends and insights for corporates, investors and startups.

Helene also leads the ecosystem awareness activities including media relationships and  startup briefings and pitch days. 

She is also actively involved in working with industry leaders and innovators, facilitating organisational innovation workshops and transformation strategies.  Helene also has an active role in numerous women in HealthTech initiatives.

Prior to joining Galen Growth, Helene was responsible for the commercialisation of the energy heritage pool for the Province of Quebec .  Before moving to Singapore, Helene spent a few years in China working on the international desk of a local trading commodity firm.

Helene holds a Business degree in Finance and a Master in Communication

Dario Heymann, PhD

Dario is Chief Research Officer and a founding member.   He leads research & market intelligence and has a passion for improving organisations’ overall strategy by grounding decisions in real-world evidence and analysis of the Digital Health ecosystem.

Dario has built HealthTech Alpha, the world’s only database and venture analytics platform dedicated to Digital Health.

Prior to Galen Growth, Dario has worked in drug discovery mainly focused on the development of novel drugs in oncology. Dario holds a doctorate in Material Science & Engineering and Masters in Material Science & Engineering, Biochemistry, and Molecular Biology.

Matt Whittingham

A true digital evangelist, Matt believes strongly that HealthTech can help transform insurers’ business and customer experience.   He brings several decades of digital experience, from companies including Microsoft, Vodafone and Singtel, and was most recently Chief Digital Officer at Manulife Asia. 

Ana Kollcaku

Ana brings a wealth of management consulting experience, most recently with EY. She has been responsible for strategic & execution projects, including health initiatives for Pfizer, Artsana & Sivantos.

Hajime Sato

Hajime leads our relationship with Japanese corporates and investors. With a background as entrepreneur & investor, Hajime connects health innovators & business to drive transformation.

Sara Schmachtenberg

With a deep conviction that digital health strategy should be based on facts, not hype, Sara leads the data and analytics insights of Galen Growth in the USA and Europe.  With 10 years of medical device experience across both corporate and startups, Sara brings a wealth of experience to our client base.

Melvin Chia

An all-round marketer and event manager, Melvin believes in creative work that resonates with the right audience. He aims to inspire digital health startups and corporates to deepen their relationships farther.

Dr Snehal Patel

Dr Patel co-founded MyDoc and is also a Managing Director of Saena Partners, a Singapore-based investment company. Previously, he was a Senior Vice President at Chandler Corporation, a multi-billion dollar investment fund based in Singapore. In this role, he founded and led the investment team responsible for investing in healthcare businesses in South and Southeast Asia. His responsibilities included leading the on-the-ground incubation and early growth of a regional healthcare chain, as well as serving on the boards of several early-stage healthcare and education businesses throughout the region.

Prior to moving to Singapore in 2008, Dr Patel practiced law at Cravath, Swaine & Moore, and LLP in New York. He received an MD from the Columbia University College of Physicians and Surgeons and a JD from Columbia Law School. Upon graduation, he served as a Clinical Fellow at the Harvard Medical School, and was offered a Fulbright scholarship to study the differences between the Singaporean and US healthcare systems. Dr Patel was a featured speaker at the 2011 Milken Global Conference and is a member of the Society of Kauffman Fellows.

More about Dr Snehal Patel

• Clinical Fellow at Harvard Medical School
• Featured speaker at 2011 Milken Global Conference

Rosaline Chow Koo

Rosaline invested $5M of her savings and borrowed another $5M to build CXA after 5 years trying to convince her previous firm to invest in Asia. Now CXA has 800k users across 20 countries in Asia is being white-labelled as the SME bancassurance platform for many banks. CXA has been awarded Insurtech of the Year, Top CEO, Global Innovations in Healthcare, Asian Human Capital Leadership Award, Asian Insurance Innovations and HR Vendor of the Year for Corp Wellness and Comp & Benefits.
 
Rosaline supervised Procter & Gamble factory lines in Iowa and then worked at Bankers Trust on Wall Street. She launched two dot-com start-ups before moving to ACE insurance. Rosaline also grew Mercer Marsh Benefits’ 14 APAC countries 800% over 8 years. She graduated from UCLA Cybernetics and Columbia Business School. 

Gavin Teo

Gavin Teo is a General Partner at Altara Ventures where he focuses on early stage investments in Southeast Asia technology. He was previously a General Partner at B Capital Group, a global venture growth fund where he led the investment committee and managed investments in digital health and consumer internet. Earlier in his career, Gavin was an investor at Comcast Ventures, a product manager at Zynga and a management consultant at Bain & Company. Gavin earned his M.B.A. from The Wharton School of the University of Pennsylvania, where he graduated as a Palmer Scholar, and holds a B.A. in Economics from Claremont McKenna College. 

Charles Toomey

An Asian Healthcare Industry expert with over 20 years experience leading and building businesses across the Asia Pacific region. Currently, Charles uses his expertise and industry knowledge to help healthcare start-ups through investment and growth accelerating their development through application of his leadership capability and leveraging his network. In 2015, Charles co-founded Action4Diabetics, a U.K. registered charity focused on tackling Type 1 Diabetes across SE Asia. 

Nawal Roy

Nawal is the Founder and CEO of Holmusk – a global digital health platform pioneering in new approaches of looking at long-term illnesses.

Over the years, Nawal has been deeply involved with serving clients across North American, Europe, South East Asia, India, China, Middle East & Africa.

Prior to this, Nawal was the Co-Founder and CEO of HelloPay (Rocket internet venture). Before leading HelloPay, he was a Junior Partner leading client advisory service line in McKinsey & Company. Before Mckinsey, Nawal was the Managing Partner of Shobhit Capital Group, an independent advisory and capital investment firm. Prior to Shobhit Capital, Nawal was a risk management specialist leading ERM initiative at Moody’s Investor Services.

Nawal is one of the founders of PRMIA where he was one of the Directors of Board of PRMIA and Regional Director of the New York Chapter. He has also worked at KPMG, Credit Suisse First Boston and Deutsche Bank.

More about Nawal Roy

• Co-founder, PRMIA
• Founder & CEO, HelloPay

Dr Ronald Ling

Dr Ling is the Founder and Managing Director of Sanus Advisory Asia, an independent advisory firm in Singapore that provides investment and transaction-related services across Asia within the healthcare industry.

A veteran of healthcare investing in Asia with over 20 years experience in consulting, operations and private equity roles, Dr Ling is also Director and Advisor to Connected Health, a Singapore-based remote monitoring and disease management company, and an occasional angel investor. Prior to setting up Sanus Asia, Dr Ling was Managing Director of Pricewaterhouse Cooper’s Healthcare practice and the firm’s Asia Healthcare Leader.

Dr Ling was previously a partner with Symphony Asia (formerly Schroder Capital Partners); a mid-sized private equity firm based in Singapore. At Symphony Dr Ling led healthcare deals and held Board appointments with Parkway Holdings (Asia’s largest private healthcare services company) and Strides Arcolab (a mid-tier listed Indian generic pharmaceutical company), among others

Dr Snehal Patel

Dr Patel co-founded MyDoc and is also a Managing Director of Saena Partners, a Singapore-based investment company. Previously, he was a Senior Vice President at Chandler Corporation, a multi-billion dollar investment fund based in Singapore. In this role, he founded and led the investment team responsible for investing in healthcare businesses in South and Southeast Asia. His responsibilities included leading the on-the-ground incubation and early growth of a regional healthcare chain, as well as serving on the boards of several early-stage healthcare and education businesses throughout the region.

Prior to moving to Singapore in 2008, Dr Patel practiced law at Cravath, Swaine & Moore, and LLP in New York. He received an MD from the Columbia University College of Physicians and Surgeons and a JD from Columbia Law School. Upon graduation, he served as a Clinical Fellow at the Harvard Medical School, and was offered a Fulbright scholarship to study the differences between the Singaporean and US healthcare systems. Dr Patel was a featured speaker at the 2011 Milken Global Conference and is a member of the Society of Kauffman Fellows.

More about Dr Snehal Patel

• Clinical Fellow at Harvard Medical School
• Featured speaker at 2011 Milken Global Conference

Jeremy Sun

Jeremy Sun is the Design Director of Orcadesign Consultants, a forward-thinking innovation and strategy consultancy firm with studios in Singapore and Malaysia. An innovation designer with over 20 years of rich experience, Jeremy has lent his expertise to start-ups, SMEs, global brands and government agencies. He works closely with his clients to reframe challenges, create compelling visions and develop business strategies. Jeremy also advocates a user-centred innovation approach and designs impactful and insightful solutions that resonate with his clients’ target markets.

An avid design educator, Jeremy also conducts collaborative workshops to build innovation capabilities amongst diverse groups and organisations. He is also active in design education and promotion, having lectured in undergraduate programs in design institutions and forums.

Recognised as an industry leader, Jeremy has also been invited to serve as jury for international awards such as iF Award. In addition, Jeremy and his team have received numerous accolades, including the President’s Design Award Singapore, Universal Design Award, IDEA Award and Geneva Innovation Awards.

More about Jeremy Sun

• Published Empathetic Technology for Ageing – Rethinking Health and Wellness for the Elderly in Singapore: Infocomm Technology Sector
• Diverse portfolio of clientele including Samsung, Sony, Hewlett-Packard, Rentokil Initial, Welch Allyn, OSIM etc
• 15 years of experience in design education in Nanyang Polytechnic (NYP), Nanyang Technological University (NTU) and National University of Singapore (NUS)